Biotech Industry: Not a Trump Stock
President-elect Donald Trump had some harsh words for the biotech industry at his first press conference since his election, affecting both health and biotech shares. This will undoubtedly sour Trump biotech relations, as well as clearly define the industry as being a target of the new administration versus being counted favorable as what we refer to as a "Trump stock."
"We have to get our drug industry coming back. Our drug.
Den vollständigen Artikel lesen ...
President-elect Donald Trump had some harsh words for the biotech industry at his first press conference since his election, affecting both health and biotech shares. This will undoubtedly sour Trump biotech relations, as well as clearly define the industry as being a target of the new administration versus being counted favorable as what we refer to as a "Trump stock."
"We have to get our drug industry coming back. Our drug.
Den vollständigen Artikel lesen ...